Nevertheless, sEH inhibition did not alter the hepatic lipid-related gene profile, which suggested an indirect role of sEH inhibition in regulating hepatic lipid metabolism in obesity, and inhibition of inflammation in peripheral tissues could not be excluded. This evidence concerns the gene EPHX2 and obesity due to melanocortin 4 receptor deficiency.